Bio-Techne (TECH) Capital Expenditures Growth (1y) (2010 - 2026)
Bio-Techne (TECH) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -37.81% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -34.23% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 22,433.30% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 142.64% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -73.62% |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | -10.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.24% |
| Dec 31, 2025 | -13.19% |
| Sep 30, 2025 | -41.53% |
| Jun 30, 2025 | -72.80% |
| Mar 31, 2025 | -38.43% |
| Dec 31, 2024 | -54.11% |
| Sep 30, 2024 | -32.52% |
| Jun 30, 2024 | 66.00% |
| Mar 31, 2024 | 39.95% |
| Dec 31, 2023 | 143.31% |
| Sep 30, 2023 | 42.24% |
| Jun 30, 2023 | -20.18% |
| Mar 31, 2023 | -22.20% |
| Dec 31, 2022 | -39.92% |
| Sep 30, 2022 | 57.43% |
| Jun 30, 2022 | 19.92% |
| Mar 31, 2022 | 42.43% |
| Dec 31, 2021 | -11.16% |
| Sep 30, 2021 | -44.51% |
| Jun 30, 2021 | -34.86% |